1. Stereoselective synthesis of (1R, 2S)-norephedrine by recombinant whole-cell biocatalysts coupling acetohydroxyacid synthase I and ω-transaminase
- Author
-
Kun-Xin Liang, Jian-Sin Lin, Chao-Hung Kao, Hsin-Hua Chan, Wei-De Lin, Yih-Yuan Chen, Chia-Chen Li, Yen-Chung Lee, and Yi-Wun Chen
- Subjects
0106 biological sciences ,0301 basic medicine ,Stereochemistry ,Bioengineering ,medicine.disease_cause ,01 natural sciences ,Applied Microbiology and Biotechnology ,Biochemistry ,law.invention ,03 medical and health sciences ,chemistry.chemical_compound ,law ,010608 biotechnology ,medicine ,Enantiomeric excess ,Escherichia coli ,Alanine ,biology ,Chemistry ,biology.organism_classification ,Phenylacetylcarbinol ,030104 developmental biology ,Biocatalysis ,Yield (chemistry) ,Recombinant DNA ,Chromobacterium violaceum - Abstract
In this study, a combined whole-cell biotransformation process was used for efficient synthesis of optically pure (1 R, 2 S )-norephedrine [(1 R, 2 S )-NE]. The genes encoding R -selective acetohydroxyacid synthase I (AHAS I) from Escherichia coli and S -selective ω-transaminase (ω-TA) from Chromobacterium violaceum BCRC10636 were cloned and over-expressed in E. coli NovaBlue cells. In the first biosynthetic step, l -phenylacetylcarbinol ( l -PAC) was produced from benzaldehyde and pyruvate by using recombinant E. coli (pQE- AHAS I) cells, with almost 100% conversion yield and 71.8% purification yield. The purified l -PAC was coupled to l -alanine by using recombinant E. coli (pQE- CvTA ) cells to produce (1 R, 2 S )-NE. This biocatalytic process was optimal at pH 6.5 to 8.0 and 37 °C, with a 1:10 ratio of l -PAC to l -alanine. Under the optimal conditions, the highest conversion yield of (1 R, 2 S )-NE was 62.2% and the enantiomeric excess value of (1 R, 2 S )-NE was more than 99%. The recombinant E. coli (pQE- CvTA ) cells could be reused for at least 20 cycles, with only a modest reduction in the conversion yield to 76.3% relative to the first cycle. Our results indicate that the combination of AHAS I- and ω-TA-expressing E. coli cells might be a potential biocatalyst for (1 R, 2 S )-NE production.
- Published
- 2018